Research Lines

Five research lines, one applied stack.

Our research is organised around five interconnected lines — each feeding the same pipeline of patented compounds, deployed software and HPC capacity that we offer to industry partners.

The five lines

Each line is a research capability and a service track — methods we publish, tools we maintain and projects we run for partners.

Discovery of bioactive compounds

Structure-based virtual screening of large compound libraries against pharmacological, agricultural and cosmetic targets — turning predictions into patented assets.

drug-repurposing structure-based design patents
Read more →

High Performance Computing

Scaling computational drug discovery to supercomputers, GPUs and containers — so a project that would take months runs in days.

GPU acceleration cluster scheduling Singularity containers
Read more →

Biophysics of Ion Channels

Molecular dynamics and free-energy approaches for ion channels and membrane proteins — applied to neurological, cardiac and metabolic targets.

molecular dynamics membrane proteins binding-energy
Read more →

QSAR & predictive modelling

Interpretable machine-learning models for ADMET, target activity and toxicity prediction — built and benchmarked with the team’s SIBILA framework.

ADMET interpretable ML QSAR
Read more →

Advanced Data Clustering

Scalable clustering methods for chemical libraries, molecular dynamics trajectories and high-dimensional biological data — the backbone of our virtual screening post-processing.

chemical clustering MD trajectories consensus
Read more →

Have a target or a question we should look at?

We can apply this stack to your specific problem — drug discovery, agri-food, cosmetics, materials or HPC scaling.

Prof. Horacio Pérez-Sánchez · hperez@ucam.edu

Sign up to receive periodic updates about last research results, software tools (recently published and in testing -premiere access-), open positions, grant calls, press releases, etc.

We don’t spam! Read our privacy policy for more info.